News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Filters
PsyBio Therapeutics Files Four U.S. Patent Cooperation Treaty (PCT) Patent Applications Further Expanding Its Patent Portfolio
PsyBio Therapeutics
Algernon Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for Ifenprodil for the Treatment of Idiopathic Pulmonary Fibrosis
Algernon Pharmaceuticals
Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout
MindBio Therapeutics
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizona
BetterLife Pharma
Awakn Life Sciences Announces Signing of Lease for Second Clinic in Norway
Awakn Life Sciences
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing
PsyBio Therapeutics
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health Conference
Mind Medicine (MindMed)
Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets
Entheon Biomedical
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
Revive Therapeutics
Lobe Sciences Provides an Update to Clinical Development Plans for Its Proprietary Psilocin Product, L-130
Lobe Sciences
Irwin Naturals Leverages Household Brand Status in Effort to be World’s Largest Chain of Psychedelic Mental Health Clinics
Irwin Naturals
Filament Health Announces New United States Patent Issuances
Filament Health
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
Wellbeing Digital Sciences
Nova Submits Phase II A Psilocybin Clinical Trial Application to Health Canada
Nova Mentis Life Science
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America
Braxia Scientific Corp.
Wellbeing Subsidiary Mindscape Treats its 1,000th Patient
Wellbeing Digital Sciences
PsyBio Therapeutics Reports Third Quarter 2022 Financial Results
PsyBio Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.